Skybiotech Healthcare Limited (BOM:512036)
India flag India · Delayed Price · Currency is INR
114.00
0.00 (0.00%)
At close: Nov 13, 2026

Skybiotech Healthcare Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
43.2570.9870.52---
Other Revenue
1.450.732.2220.020.540.23
44.771.7172.7420.020.540.23
Revenue Growth
-43.29%-1.41%263.26%3597.53%138.36%16.26%
Cost of Revenue
26.2540.8237.73---
Gross Profit
18.4530.8935.0120.020.540.23
Selling, General & Admin
16.3917.6519.630.190.120.16
Other Operating Expenses
26.627.0434.11.080.480.43
Operating Expenses
47.5149.4759.141.270.620.61
Operating Income
-29.06-18.58-24.1418.75-0.07-0.38
Interest Expense
-0.11-0.15----
Interest & Investment Income
--0.01---
Currency Exchange Gain (Loss)
---0.01---
Other Non Operating Income (Expenses)
2.082.08-0.12-0--
EBT Excluding Unusual Items
-27.09-16.65-24.2618.75-0.07-0.38
Asset Writedown
-0.02-0.02----
Pretax Income
-27.11-16.67-24.2618.75-0.07-0.38
Income Tax Expense
-5.5-5.5-0.573.4-00
Net Income
-21.61-11.17-23.6915.35-0.07-0.38
Net Income to Common
-21.61-11.17-23.6915.35-0.07-0.38
Net Income Growth
------
Shares Outstanding (Basic)
222211
Shares Outstanding (Diluted)
222211
Shares Change
-27.86%-0.22%-12.76%84.14%--
EPS (Basic)
-12.48-6.70-14.188.02-0.07-0.36
EPS (Diluted)
-12.48-6.70-14.188.02-0.07-0.36
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
--15.18-13.68-13.37-3.736.1
Free Cash Flow Per Share
--9.11-8.19-6.98-3.595.86
Gross Margin
41.28%43.08%48.13%100.00%100.00%100.00%
Operating Margin
-65.02%-25.91%-33.18%93.64%-13.62%-166.50%
Profit Margin
-48.35%-15.57%-32.57%76.68%-13.37%-166.58%
Free Cash Flow Margin
--21.17%-18.80%-66.76%-688.68%2683.86%
EBITDA
-24.86-13.79-18.7218.76-0.06-0.36
EBITDA Margin
-55.61%-19.23%-25.74%93.68%-10.83%-156.29%
D&A For EBITDA
4.214.795.420.010.020.02
EBIT
-29.06-18.58-24.1418.75-0.07-0.38
EBIT Margin
-65.02%-25.91%-33.18%93.64%-13.62%-166.50%
Effective Tax Rate
---18.12%--
Revenue as Reported
47.0274.0474.3520.020.540.23
Advertising Expenses
-0.02-0.040.010.01